OC
PDLI

Oppenheimer & Co’s PDL BioPharma, Inc. PDLI Stock Holding History

Oppenheimer & Co’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,188
Closed -$42K – 1437
2020
Q3 		$42K Sell
13,188
-2,000
-13% -$6.39K ﹤0.01% 1266
2020
Q2 		$44K Hold
15,188
– – ﹤0.01% 1239
2020
Q1 		$43K Hold
15,188
– – ﹤0.01% 1160
2019
Q4 		$49K Hold
15,188
– – ﹤0.01% 1256
2019
Q3 		$33K Hold
15,188
– – ﹤0.01% 1239
2019
Q2 		$48K Hold
15,188
– – ﹤0.01% 1282
2019
Q1 		$57K Hold
15,188
– – ﹤0.01% 1324
2018
Q4 		$44K Hold
15,188
– – ﹤0.01% 1213
2018
Q3 		$40K Hold
15,188
– – ﹤0.01% 1329
2018
Q2 		$36K Hold
15,188
– – ﹤0.01% 1311
2018
Q1 		$45K Buy
15,188
+3,700
+32% +$10.1K ﹤0.01% 1312
2017
Q4 		$31K Sell
11,488
-3,700
-24% -$11.4K ﹤0.01% 1301
2017
Q3 		$51K Hold
15,188
– – ﹤0.01% 1268
2017
Q2 		$38K Hold
15,188
– – ﹤0.01% 1279
2017
Q1 		$34K Sell
15,188
-500
-3% -$1.11K ﹤0.01% 1267
2016
Q4 		$33K Hold
15,688
– – ﹤0.01% 1258
2016
Q3 		$53K Buy
15,688
+1,125
+8% +$3.57K ﹤0.01% 1238
2016
Q2 		$46K Buy
+14,563
New +$48.6K ﹤0.01% 1192
2015
Q4 		– Sell
-10,310
Closed -$52K – 1458
2015
Q3 		$52K Buy
+10,310
New +$59.1K ﹤0.01% 1303
2014
Q4 		– Sell
-11,000
Closed -$82K – 1582
2014
Q3 		$82K Sell
11,000
-3,710
-25% -$34.4K ﹤0.01% 1360
2014
Q2 		$142K Buy
14,710
+310
+2% +$2.76K ﹤0.01% 1315
2014
Q1 		$120K Hold
14,400
– – ﹤0.01% 1320
2013
Q4 		$122K Sell
14,400
-3,000
-17% -$25.3K ﹤0.01% 1299
2013
Q3 		$139K Hold
17,400
– – ﹤0.01% 1217
2013
Q2 		$135K Buy
+17,400
New +$136K 0.01% 1171

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Oppenheimer & Co's PDLI Position: Q4 2020 in Review

Oppenheimer & Co sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 13,188 shares — an estimated $42K sold.

Oppenheimer & Co first reported a position in PDLI in Q2 2013 and held it in 25 quarters. The position peaked at $142K in Q2 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Oppenheimer & Co reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 13,188 PDL BioPharma, Inc. shares in Q4 2020, an estimated $42K.
  • Oppenheimer & Co first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 25 quarters.
  • Oppenheimer & Co's PDL BioPharma, Inc. position peaked at $142K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.